The noninvasive detection of Helicobacter pylori and its resistance to clarithromycin could
revolutionize the management of H. pylori-infected patients by tailoring eradication treatment …

The gram-negative bacterium Helicobacter pylori (H. pylori) causes chronic gastritis, gastric
and duodenal ulcers, gastric cancer and mucosa-associated lymphoid tissue lymphoma …

Eradication therapy for Helicobacter pylori is recommended in a number of clinical
conditions. In this article, we discuss the epidemiology and cellular mechanisms that result …

Despite the declining trend of Helicobacter pylori (H. pylori) prevalence around the globe,
ongoing efforts are still needed to optimize current and future regimens in view of the …

A proton-pump inhibitor (PPI), clarithromycin-based, triple therapy has been the
recommended treatment for Helicobacter pylori eradication for the past 15 years. Due to a …

The array of tests that can be used for diagnosis of Helicobacter pylori infection is large, and
it can be confusing to define which test to use particularly in children where results may not …

As more original molecular protocols and subsequent modifications are described in the
literature, it has become difficult for those not directly involved in the development of these …

Antibiotic resistance in Helicobacter pylori (H. pylori) is the main factor affecting the efficacy
of current treatment methods against infection caused by this organism. The traditional …

The management of Helicobacter pylori (H. pylori) infection treatment differs from the
common treatment protocol for other infectious diseases. Because culture-or molecular …

In the present study, novel real-time PCR assays targeting the fungal ITS2 region were
developed for the detection and differentiation of medically important Aspergillus species …